Fords, NJ, United States of America

Oksana C Palyha

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oksana C Palyha. Retrieved from https://idiyas.com/inventor/oksana-c-palyha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Oksana C Palyha: Innovator in Canine Growth Hormone Research

Introduction

Oksana C Palyha is a notable inventor based in Fords, NJ (US). He has made significant contributions to the field of veterinary science, particularly in the study of canine growth hormones. His innovative work has led to the development of a unique patent that addresses important aspects of canine health.

Latest Patents

Oksana C Palyha holds a patent for a novel canine cDNA sequence that encodes the canine growth hormone secretagogue receptor (GHSR) protein. This patent includes methods for expressing the canine GHSR protein in recombinant systems. Additionally, it provides techniques for identifying agonists and antagonists of the canine GHSR, which could have implications for canine health and treatment.

Career Highlights

Oksana is currently employed at Merck & Company, Inc., where he continues to advance his research in the field. His work is characterized by a commitment to improving the understanding of canine biology and health.

Collaborations

He has collaborated with notable colleagues, including Andrew D Howard and Carina P Tan, to further enhance the impact of his research. These collaborations have contributed to the advancement of knowledge in the field of veterinary science.

Conclusion

Oksana C Palyha's innovative contributions to canine growth hormone research exemplify the importance of scientific inquiry in improving animal health. His patent and ongoing work at Merck & Company, Inc. highlight his dedication to advancing veterinary science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…